Bimodal Imaging Probes for Combined PET and OI: Recent Developments and Future Directions for Hybrid Agent Development

Figure 4

Structures of dually labeled PET radionuclide and fluorescent dye comprising peptides developed for in vivo tumor imaging with PET and OI.